| Health / Medical Topics |
Febuxostat
An orally available, non-purine inhibitor of xanthine oxidase with uric acid lowering activity. Upon oral administration, febuxostat selectively and noncompetitively inhibits the activity of xanthine oxidase, an enzyme that converts oxypurines, including hypoxanthine and xanthine, into uric acid. By inhibiting xanthine oxidase, uric acid production is reduced and serum uric acid levels are lowered. Febuxostat may provide protection against acute renal failure caused by the excessive release of uric acid that occurs upon massive tumor cell lysis resulting from the treatment of some malignancies. (NCI Thesaurus)
YOU MAY ALSO LIKE
The second month of the year in the Gregorian calendar.
A condition marked by fever and a lower-than-normal number of neutrophils in the blood. A neutrophil is a type of white blood…
Indicates the direction and/or type of the SeqFeature, i.e. whether it is in the 5' or 3' direction, is double stranded,…
A FeatureReporterMap is the description of how source features are transformed into a target reporter. These would map replicate features for…
As part of the map information, allows the association of one or more differences in the BioMaterial on a feature from the…
Specialized DesignElementDimension to hold Features. (caMAGE)
